Ingredient record · Blood pressure medicine (ARB)
Telmisartan: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
5 entries containing Telmisartan are on India's banned-drugs list, and 3 are banned today. 200 batches of medicines containing Telmisartan failed a government lab test between May 2019 and July 2026, from 107 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
3
Banned combinations in force
2
Other listed orders (stayed, restricted, quashed)
200
Batches failed a lab test
Jul 2026
Latest lab alert
Is it banned? Our answer pages
Not banned · spurious batches reported
Not banned · spurious batches reported
Not banned · spurious batches reported
Not banned · spurious batches reported
On the banned-drugs list
Telmisartan on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Telmisartan + Ramipril + HydrochlorothiazideFixed-dose combination · cardiac | Banned | S.O. 252(E) | 11 January 2019 | Other orders | One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021. |
| Clindamycin + TelmisartanFixed-dose combination · antibiotics | Banned | S.O. 4454(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Telmisartan + MetforminFixed-dose combination · diabetes | Banned | S.O. 4694(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Clindamycin + TelmisartanFixed-dose combination · antibiotics | Quashed | S.O. 786(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Telmisartan + MetforminFixed-dose combination · diabetes | Quashed | S.O. 1041(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Telmisartan | 136 | 65 | Jul 2026 |
| Telmisartan Amlodipine | 19 | 17 | Jul 2026 |
| Telmisartan Hydrochlorothiazide | 10 | 8 | Jul 2026 |
| Telmisartan Amlodipine Besylate | 3 | 3 | Jun 2026 |
| Telmisartan Savtel | 2 | 1 | Dec 2025 |
| Telmisartan Hydrochlorothizide | 2 | 2 | Nov 2025 |
| Metoprolol Succinate Telmisartan | 2 | 2 | Jan 2025 |
| Telmicept | 2 | 1 | Jul 2021 |
| Telapp Mt | 1 | 1 | Jun 2025 |
| Telmisartan Amlodipine Tabletsip | 1 | 1 | May 2025 |
| Telivi H Telmisartan Hydrochorothiazide | 1 | 1 | Apr 2025 |
| Telmivaz Telmisartan | 1 | 1 | Mar 2025 |
| Telso | 1 | 1 | Mar 2025 |
| Telvas | 1 | 1 | Mar 2025 |
| Telvas Am | 1 | 1 | Mar 2025 |
| Telvas H / | 1 | 1 | Mar 2025 |
| Telmisartan Hydrochloro Thiazide | 1 | 1 | Feb 2025 |
| Telmisartan Telmasil | 1 | 1 | Feb 2025 |
| Telma H Telmisartan Hydrochlorot Hiazide | 1 | 1 | Aug 2024 |
| Telmisartan Andamlodipine | 1 | 1 | May 2024 |
| Telmisartan Tables | 1 | 1 | Apr 2024 |
| Telgo | 1 | 1 | Dec 2023 |
| Telmisartan Chlorthalidone | 1 | 1 | Aug 2023 |
| Teripil | 1 | 1 | May 2023 |
| Telmirid | 1 | 1 | Mar 2023 |
| Telma | 1 | 1 | Feb 2023 |
| Loose | 1 | 0 | Jan 2023 |
| Telmistad | 1 | 1 | Dec 2022 |
| Telione | 1 | 1 | Mar 2022 |
| Telmopac Am Telmisartan Amlodipine | 1 | 1 | Nov 2021 |
Top 30 of 32 products by number of batches.
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Telmisartan Tablets IP 40mg | STS-114Mfg 2025-05 · Exp 2027-04 | Marc Lifesciences SikkimSikkim | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Telmisartan Tablets IP 40 mg | 493TTF004Mfg 2025-07 · Exp 2027-06 | Swiss Garnier Life SciencesHimachal Pradesh | The sample does not conform to IP standards. If fails the test Dissolution as per IPDissolution | DTL, TVPMState lab | Jul 2026 |
| Telmisartan Tablets IP 40 mg | 493TTF014Mfg 2025-08 · Exp 2027-07 | Swiss Garnier Life SciencesHimachal Pradesh | The sample does not conform to IP standards. It fails the test Dissolution as per IPDissolution | DTL, TVPMState lab | Jul 2026 |
| Telmisartan Tablets IP 40 mg | CT25624Mfg 2025-12 · Exp 2027-11 | Century Nova Drugs Pvt. Ltd | The Sample does not Comply for Description as the Tablets shows uneven Light Brown coloured Spots all over the Surface of the TabletsDescription | FDAL, Chhatrapati SambhajinagarState lab | Jul 2026 |
| Telmisartan Tablets IP 20 mg | HT250167Mfg 2025-08 · Exp 2027-07 | MEDICAMEN Biotech LtdUttarakhand | The sample received does not conform to the I.P. 2022 standard with respect to the test for Dissolution.Dissolution | CDTL, MumbaiCDSCO lab | Jul 2026 |
| Telmisartan & Hydrochlorothiazide Tablets IP | AMT-2460Mfg 2025-11 · Exp 2027-10 | Avalon Medicines Pvt. LtdHaryana | The sample received does not conform to i.p. 2022 specification with respect to the test for Dissolution of hydrochlorothiazide only.Dissolution | CDTL, HyderabadCDSCO lab | Jul 2026 |
| Telmisartan & Amlodipine Tablets I.P. | 2510095Mfg 2025-10 · Exp 2027-09 | Sai sarvaa Biotech Pvt. Ltd | 01. ASSAY OF AMLODIPINE I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab | Jul 2026 |
| Telmisartan Tablets IP 80mg | PT50022AMfg 2025-11 · Exp 2027-10 | Gnosis Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab | Jun 2026 |
| Telmisartan Tablets IP 40mg | GTM94Mfg 2025-05 · Exp 2027-04 | Super Formulations Pvt. Ltd | DissolutionDissolution | DTL, Chennai-06State lab | Jun 2026 |
| Telmisartan Tablets IP 40mg | MT-032673Mfg 2026-03 · Exp 2028-02 | Merion Care Pvt.LtdHimachal Pradesh | Dissolution and ContentDissolution | DTL, Chennai-06State lab | Jun 2026 |
| Telmisartan Tablets IP 40mg | RT-251154Mfg 2025-11 · Exp 2027-10 | Relief Biotech Pvt. LtdDelhi | 1. Description 2. Dissolution (7Units Foumd to be less than 60% against I.P Limit of max. Two Units to be less than 60% against labeled claim also 7units found to be less than 50% against I.P Limit of No Unit to be less than 50% against Labeled claim.)Dissolution | SDTL, PunjabState lab | Jun 2026 |
| Telmisartan Tablets IP 40 mg | TM5143Mfg 2025-09 · Exp 2027-08 | Kerala State Drugs and Pharmaceuticals LtdKerala | It fails the Descriptive part for tablets as per IP, as specified in the laboratory protocol. As per IP, tablets should have sufficient hardness to withstand handling without crumbling or breaking. These tablets are soft and in powdered condition and cannot be removed from the strips in intact formOther | DTL, TVPMState lab | Jun 2026 |
| Telmisartan Tablets IP 40 mg | 493TTF009Mfg 2025-08 · Exp 2027-07 | Swiss Garnier Life SciencesHimachal Pradesh | The sample does not conform to IP standards with respect to the test Dissolution.Dissolution | RDTL, ErnakulamState lab | Jun 2026 |
| Telmisartan Tablets IP 40 Mg | SPE250642Mfg 2025-05 · Exp 2027-04 | Aristo Pharmaceuticals Pvt. LtdSikkim | The sample does not conform to I.P. w.r.to the tests for Identification and AssayAssay | SDTL, GuwahatiState lab | Jun 2026 |
| Telmisartan Tablets IP 20mg | PRT2601-29Mfg 2026-01 · Exp 2027-12 | Regent Ajanta Biotech 86-87Uttarakhand | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab | Jun 2026 |
Showing 15 of 200 records
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.